RobertWSimmsMDProfessor of Medicine
Rheumatology • Lebanon, NHRheumatoid Arthritis & Related, Scleroderma & Related
Professor of Medicine, Boston University
Dr. Simms is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-8622
Education & Training
Boston University Medical CenterFellowship, Rheumatology, 1985 - 1987
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1980 - 1981
University of Rochester School of Medicine and DentistryClass of 1980
Certifications & Licensure
NY State Medical License 1982 - Present
NH State Medical License 2020 - 2026
VT State Medical License 2022 - 2026
MA State Medical License 1982 - 2023
ME State Medical License 2020 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Boston Magazine Castle Connolly, 2008-2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Scleroderma Treatment With Autologous Transplant (STAT) Study Start of enrollment: 2011 Sep 15
- Join now to see all
Publications & Presentations
PubMed
- 142 citationsAbatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled TrialDinesh Khanna, Cathie Spino, Sindhu R. Johnson, Lorinda Chung, Michael L. Whitfield
Arthritis & Rheumatology. 2020-01-01 - 295 citationsTocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Jonathan G. Goldin, Grace Kim
The Lancet. Respiratory Medicine. 2020-10-01 - 328 citationsMyeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.Keith M. Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney
The New England Journal of Medicine. 2018-01-03
Journal Articles
- Serum Biomarker for Diagnostic Evaluation of Pulmonary Arterial Hypertension in Systemic SclerosisHarrison W Farber, Kari Roberts, Nicholas Hill, Robyn Domsic, Robert W Simms, BioMed Central
Grant Support
- Core B Clinical CoreNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- High-Dose Immunosuppressive Therapy Using Total Body IrradiationNational Center For Research Resources2007
- Infusion Of Recombinant Human Relaxin In Patients W/ SclerodermaNational Center For Research Resources1999–2000
- Muscle Metabolism And Muscle Fatigue In Fibromyalgia SyndromeNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1990–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
